N-[2-[6-(2,4-dichlorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide
C24H28Cl2N2O2S — CID 166910566
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[6-(2,4-dichlorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide
N-[2-[6-(2,4-dichlorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide (PubChem CID 166910566) has the molecular formula C24H28Cl2N2O2S and a molecular weight of 479.47 g/mol. Its IUPAC name is N-[2-[6-(2,4-dichlorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide.
Molecular Properties
| Compound Name | N-[2-[6-(2,4-dichlorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide |
|---|---|
| PubChem CID | 166910566 |
| Molecular Formula | C24H28Cl2N2O2S |
| Molecular Weight | 479.47 g/mol |
| Exact Mass | 478.12 |
| IUPAC Name | N-[2-[6-(2,4-dichlorophenyl)-1-(2,2-dimethylpropyl)indol-3-yl]ethyl]cyclopropanesulfonamide |
| SMILES | CC(C)(C)Cn1cc(CCNS(=O)(=O)C2CC2)c2ccc(-c3ccc(Cl)cc3Cl)cc21 |
| InChI | InChI=1S/C24H28Cl2N2O2S/c1-24(2,3)15-28-14-17(10-11-27-31(29,30)19-6-7-19)21-8-4-16(12-23(21)28)20-9-5-18(25)13-22(20)26/h4-5,8-9,12-14,19,27H,6-7,10-11,15H2,1-3H3 |
| InChIKey | FJSAICXJDOUYNG-UHFFFAOYSA-N |
| XLogP | 6.29 |
| TPSA | 51.10 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 479.47 |
| LogP ≤ 5 | 6.29 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166910566 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.